Amy Calistri
Stock of the Month
Stephen Leeb
Income Performance Report
Roger Conrad
The Utility Forecaster
Paul McWilliams
Next Inning

Adrian Day eyes junior miners


Bookmark and Share

By Adrian Day, editor The Global Analyst

Adrian Day The Global Analyst"Despite the expected correction, there is much further to go for gold and gold stocks. Gold saw its ninth annual advance, to new highs before a 10% correction at the end of the year.

Gold certainly was helped by the weak dollar—and the year-end sell-off was provoked by a dollar recovery—but it’s much more than an anti-dollar play.



Advertisement
Banner

"Gold saw its ninth annual advance, to new highs before a 10% correction at the end of the year. Gold certainly was helped by the weak dollar—and the year-end sell-off was provoked by a dollar recovery—but it’s much more than an anti-dollar play.

 

"Gold is up in terms of all currencies, boosted by concern about inflation and extraordinarily low interest rates. Mostly, it’s a vote of no confidence in the world’s paper monies, and skeptism of central bankers’ abilities to effect stable money, and specifically to exit stimulus programs in an orderly manner.

"Nothing has changed, and gold is becoming a new de-facto alternate currency. And there is a lot further to go.

"Most significant perhaps, central banks have switched from being net sellers to buyers. As we have discussed before, banks that built up their reserves in the last couple of decades tend to have the highest levels of reserves but the lowest proportion of gold (India, China, Korea etc.).

"The overall level of gold in central bank reserves has dropped from over 30% a decade ago to just over 10%, the lowest level ever. The ease with which India (and Mauritius) scooped up half the IMF’s gold for sale shows clearly that demand overhang is not a problem. Central banks are likely to be net buyers for years to come.

"Producers are still selling at historically low prices relative to bullion, and at the lowest price-to-earnings and price-to cash flow ratios in over 20 years. The major producers have problems, however,most importantly the difficulty in replacing.

"Given these difficulties, we favor the juniors and exploration companies; these dominate our buy list. This is where the best value is often found as well as the growth.

"So we are comfortable holding and adding to the exploration stocks, on a selective and patient basis. Among the stocks on our list, at current price levels, we would look to buy Vista Gold (NYSE: VGZ), Virginia Mines (Toronto: VGQ), and Royal Gold (NASDAQ: RGLD)."

Learn more about this financial newsletter at Adrian Day's The Global Analyst.


Banner
News Flash

Linkedin: Professional profits
by Leo Fasciocco, editor Ticker Tape Digest

Online professional network operator Linkedin (LNKD) recently moved above its technical breakout point of $108.53. We now target a move to $138.


Read more...

 

Tap in to water stocks
by Doug Fabian, editor Making Money Alert

As we prepare for the summer heat, water presents a significant investment opportunity -- especially as states such as California and Texas face droughts. The PowerShares Water Resource ETF (PHO) presents one way to invest in water's untapped potential.


Read more...


   

Pax World: High yield exception
by Amy Calistri, editor The Daily Paycheck

I generally prefer closed-end or exchange-traded funds because the fees tend to be lower. But I made a special case for Pax World High Yield Bond (PAXHX); this high-yield bond fund is my only open-ended mutual fund holding.


Read more...

 

Amgen: Biotech DRIP
by Chuck Carlson, editor DRIP Investor

Amgen (AMGN) is one of the oldest and largest players in the biotechnology area. It pioneered the development of products based on advances in recombinant DNA and molecular biology, launching the biotechnology industry’s first blockbuster medicines.


Read more...

 

Fidelity fund expert looks to Japan
by Jim Lowell, editor Fidelity Investor

In my May Marketwatch investment strategy column I noted, “Set against the backdrop of having already been thrown out with the Eurozone’s bathwater, I like Japan’s marketplace overall and, more specifically, their small cap marketplace which caters to domestic counter traffic.”


Read more...

 

MOO: Market Vectors Agribusiness
by Doug Fabian, editor Making Money Alert

Everyone needs food to survive, so wouldn't it be great to make money from it? We can. The global agriculture business provides a fairly stable investment with growth potential. In particular, I am looking at Market Vectors Agribusiness ETF (MOO).


Read more...

 

Celgene: Selloff creates opportunity
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

Celgene (CELG) develops and assists in the marketing of drugs to treat cancer and infl ammatory diseases. It acquired several companies recently, which will expand its product line and add promising products in various stages of development.


Read more...

 

Senior housing reits for income
by Brian Hicks, editor Wealth Advisory

Omega Healthcare Investors (OHI) and Medical Properties Trust (MPW) caters to the senior housing/assisted living facilities. Given the growing senior population, it makes sense to be somewhat over-exposed to companies that target this market.


Read more...

 

Buffett: Still banking on banks
by Ron Rowland, editor All Star Investor

Wise investors zero in on conflicting data points. Warren Buffett, the wisest investor of all, provided plenty to consider at the Berkshire Hathaway annual meeting. 


Read more...

 

Questcor: 'Exponential demand'
by Dennis Slothower, editor Stealth Stocks

Questcor Pharmaceuticals (QCOR), our latest featured stock of the month, is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary